GPX4 and hepatocellular carcinoma: Xu et al. (2020) revealed that circIL4R functions as an oncogene to accelerate tumor development and suppress ferroptosis through the miR-541-3p/GPX4 cascade in HCC, unveiling a distinctive regulatory pathway circIL4R/miR-541-3p/GPX4 [119].